BEAM
Price
$17.00
Change
+$0.38 (+2.29%)
Updated
Apr 17 closing price
Capitalization
1.7B
24 days until earnings call
HALO
Price
$58.79
Change
-$0.03 (-0.05%)
Updated
Apr 17 closing price
Capitalization
7.26B
24 days until earnings call
Ad is loading...

BEAM vs HALO

Header iconBEAM vs HALO Comparison
Open Charts BEAM vs HALOBanner chart's image
Beam Therapeutics
Price$17.00
Change+$0.38 (+2.29%)
Volume$1.14M
Capitalization1.7B
Halozyme Therapeutics
Price$58.79
Change-$0.03 (-0.05%)
Volume$1.52M
Capitalization7.26B
BEAM vs HALO Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. HALO commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and HALO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (BEAM: $17.00 vs. HALO: $58.79)
Brand notoriety: BEAM and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 46% vs. HALO: 101%
Market capitalization -- BEAM: $1.7B vs. HALO: $7.26B
BEAM [@Biotechnology] is valued at $1.7B. HALO’s [@Biotechnology] market capitalization is $7.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while HALO’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • HALO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than HALO.

Price Growth

BEAM (@Biotechnology) experienced а +16.20% price change this week, while HALO (@Biotechnology) price change was +1.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

HALO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.26B) has a higher market cap than BEAM($1.7B). HALO YTD gains are higher at: 22.966 vs. BEAM (-31.452). HALO has higher annual earnings (EBITDA): 657M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. HALO (596M). BEAM has less debt than HALO: BEAM (161M) vs HALO (1.51B). HALO has higher revenues than BEAM: HALO (1.02B) vs BEAM (63.5M).
BEAMHALOBEAM / HALO
Capitalization1.7B7.26B23%
EBITDA-383.98M657M-58%
Gain YTD-31.45222.966-137%
P/E RatioN/A17.14-
Revenue63.5M1.02B6%
Total Cash851M596M143%
Total Debt161M1.51B11%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
11
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
51
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMHALO
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
66%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.29%
CRSP - BEAM
71%
Closely correlated
-0.03%
NTLA - BEAM
63%
Loosely correlated
+5.39%
RXRX - BEAM
63%
Loosely correlated
+3.38%
DNLI - BEAM
58%
Loosely correlated
+1.51%
VERV - BEAM
57%
Loosely correlated
+1.77%
More

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with IDYA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
-0.05%
IDYA - HALO
38%
Loosely correlated
+5.56%
DNLI - HALO
36%
Loosely correlated
+1.51%
BEAM - HALO
36%
Loosely correlated
+2.29%
AVTE - HALO
35%
Loosely correlated
+2.61%
VIR - HALO
35%
Loosely correlated
+1.20%
More